Intercept Pharmaceuticals

Industry / private company


Location: New York, NY, United States (USA) (US) US

ISNI: 0000000446846925

ROR: https://ror.org/01sx6jc36

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

EXPERT CONSENSUS CRITERIA AND PRACTICAL RECOMMENDATIONS FOR PBC CARE IN THE COVID-19 ERA AND BEYOND (2021) Berenguer M, Kremer A, Hirschfield G, Jones D, Leroy V, Adekunle F, Carbone M Conference contribution LONG-TERM EFFICACY AND SAFETY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS: RESPONDER ANALYSIS OF OVER 5 YEARS OF TREATMENT IN THE POISE TRIAL (2020) Hansen BE, Jones D, Carbone M, Bowlus CL, Nevens F, Kremer A, Liberman A, et al. Conference contribution LONG-TERM EFFICACY AND SAFETY OF OBETICHOLIC ACID IN PATIENTS WITH PBC FROM THE POISE TRIAL GROUPED BIOCHEMICALLY BY RISK OF DISEASE PROGRESSION (2020) Bowlus CL, Trauner MH, Kremer A, Liberman A, Malecha ES, Macconell L, Nevens F Conference contribution Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary Cholangitis (2020) Bowlus CL, Pockros PJ, Kremer A, Parés A, Forman LM, Drenth JP, Ryder SD, et al. Journal article OBETICHOLIC ACID TREATMENT IS ASSOCIATED WITH IMPROVED COLLAGEN MORPHOMETRY IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (2019) Kremer A, Bowlus CL, Bedossa P, Pares A, Forman LM, Drenth JPH, Ryder S, et al. Conference contribution Long-term obeticholic acid treatment is associated with improvements in collagen morphometry in patients with primary biliary cholangitis (2019) Kremer A, Bowlus C, Bedossa P, Pares A, Forman L, Drenth JP, Ryder S, et al. Conference contribution Three years of obeticholic Acid (OCA) therapy results in histological improvements in patients with primary biliary cholangitis: further analysis of the POISE Biopsy substudy (2019) Bowlus CL, Pockros PJ, Kremer A, Pares A, Forman LM, Drenth JPH, Ryder S, et al. Conference contribution Long-Term Obeticholic Acid (OCA) treatment associated with reversal or stabilization of fibrosis/cirrhosis in patients with Primary Biliary Cholangitis (PBC) (2018) Bowlus C, Pockros P, Kremer A, Pares A, Forman L, Drenth JP, Ryder S, et al. Conference contribution